33 phenotypes from 2 alleles in 2 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ddx3xtm1.1Lyou/Ddx3x+ Edil3Tg(Sox2-cre)1Amc/Edil3+ involves: 129 * C57BL/6 * CBA	no abnormal phenotype detected	J:231798
Ddx3xtm1.1Lyou/Y Edil3Tg(Sox2-cre)1Amc/Edil3+ involves: 129 * C57BL/6 * CBA	abnormal allantois morphology	J:231798
	abnormal brain development	J:231798
	abnormal cell cycle	J:231798
	abnormal cell physiology	J:231798
	abnormal developmental patterning	J:231798
	abnormal embryo turning	J:231798
	abnormal head fold morphology	J:231798
	abnormal myocardial trabeculae morphology	J:231798
	abnormal neural tube closure	J:231798
	embryonic growth retardation	J:231798
	embryonic lethality prior to tooth bud stage	J:231798
	failure of chorioallantoic fusion	J:231798
	increased embryonic tissue cell apoptosis	J:231798
	increased mitotic index	J:231798
	microcephaly	J:231798
	pericardial effusion	J:231798
	preweaning lethality, complete penetrance	J:231798
	small allantois	J:231798
Ddx3xtm1.2Lyou/Y involves: 129 * C57BL/6	decreased trophoblast giant cell number	J:231798
	embryonic growth retardation	J:231798
	embryonic lethality between implantation and placentation, incomplete penetrance	J:231798
	embryonic lethality prior to organogenesis, complete penetrance	J:231798
Ddx3xtm1.2Lyou/Ddx3x+ involves: 129 * C57BL/6	abnormal placenta vasculature	J:231798
	abnormal placental labyrinth vasculature morphology	J:231798
	abnormal trophoblast giant cell morphology	J:231798
	decreased spongiotrophoblast cell number	J:231798
	decreased spongiotrophoblast size	J:231798
	decreased trophoblast giant cell number	J:231798
	edema	J:231798
	embryonic growth retardation	J:231798
	hemorrhage	J:231798
	lethality throughout fetal growth and development, incomplete penetrance	J:231798
	normal mortality/aging	J:231798
	preweaning lethality, complete penetrance	J:231798
	small placenta	J:231798
	ventricular septal defect	J:231798